Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Parkinson's Disease, Lewy Body”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04739423
What this trial is testing

Clenbuterol (CST-103) Co-administered With Nadolol (CST-107) in Subjects With Neurodegenerative Disorders

Who this might be right for
Mild Cognitive Impairment, Lewy Body Dementia, Parkinson's Disease Rapid Eye Movement Sleep Behavior Disorder, Parkinson's Disease Dementia
CuraSen Therapeutics, Inc. 41
Not applicableStudy completedNCT00465790
What this trial is testing

Research of Biomarkers in Parkinson Disease

Who this might be right for
Parkinson DiseaseMultiple System AtrophyProgressive Supranuclear Palsy+3 more
Institut National de la Santé Et de la Recherche Médicale, France 219
Testing effectiveness (Phase 2)UnknownNCT04167813
What this trial is testing

Trial of Ondansetron as a Parkinson's HAllucinations Treatment

Who this might be right for
Parkinson's HallucinationsDementia With Lewy Bodies
University College, London 168
Not applicableLooking for participantsNCT03402919
What this trial is testing

Comprehensive Assessment of Neurodegeneration and Dementia

Who this might be right for
DementiaMild Cognitive Impairment (MCI)Subjective Cognitive Impairment+7 more
McGill University 1,573
Not applicableStudy completedNCT04649164
What this trial is testing

Learning to PERSEVERE: Peer Mentor Support and Caregiver Education in Lewy Body Dementia

Who this might be right for
Lewy Body DiseaseParkinson Disease DementiaDementia With Lewy Bodies
Rush University Medical Center 87
Large-scale testing (Phase 3)Study completedNCT03670953
What this trial is testing

Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Participants With Motor Fluctuations

Who this might be right for
Parkinson's Disease (Disorder)
Impax Laboratories, LLC 630
Not applicableLooking for participantsNCT03019757
What this trial is testing

Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease

Who this might be right for
Alzheimer's DiseaseLewy Body DementiaParkinson's Disease
Douglas Scharre 76
Post-approval studies (Phase 4)Not Yet RecruitingNCT07806019
What this trial is testing

Metformin in Parkinson's Disease: Safety and Efficacy

Who this might be right for
Parkinsons Disease (PD)
Jinnah Medical & Dental College 70
Not applicableStudy completedNCT05638815
What this trial is testing

An Observational Study of Parkinson's Disease and Other Synucleinopathies (EASE-PD)

Who this might be right for
Parkinson's DiseaseMultiple System Atrophy
SciNeuro 89
Not applicableStudy completedNCT00880347
What this trial is testing

Blood Gene Expression Signature in Patients Diagnosed With Probable Alzheimer's Disease Compared to Patients Suffering From Other Types of Dementia

Who this might be right for
Alzheimer's DiseaseDementia
Exonhit 550
Not applicableUnknownNCT06439355
What this trial is testing

Single-center Study of Gustation in Idiopathic Parkinson's Disease and Lewy Body Disease Using Gustatory Evoked Potential Analysis

Who this might be right for
Idiopathic Parkinson's Disease and Lewy Body Disease
Centre Hospitalier Universitaire Dijon 66
Not applicableLooking for participantsNCT06629207
What this trial is testing

Artificial Intelligence in Molecular Imaging: Predicting Parkinson's Risk in REM Sleep Behavior Disorder

Who this might be right for
Parkinson DiseaseREM Sleep Behavior DisorderDementia, Lewy Body
Insel Gruppe AG, University Hospital Bern 20
Not applicableWithdrawnNCT04266457
What this trial is testing

Establishing Alpha-synuclein RT-QuIC Assay as a Diagnostic Technique in REM Sleep Behaviour Disorder

Who this might be right for
Sleep Disorder Rem Sleep BehaviorParkinson's Disease, Lewy Body
University of Edinburgh
Not applicableLooking for participantsNCT03233646
What this trial is testing

Retinal Imaging in Neurodegenerative Disease

Who this might be right for
Alzheimer's DiseaseMild Cognitive ImpairmentParkinson's Disease+12 more
Duke University 2,000
Not applicableLooking for participantsNCT07790744
What this trial is testing

A Comprehensive, Multimodal Characterization of Prodromal PD in Subjects With RBD

Who this might be right for
REM Sleep Behavior DisorderSynucleinopathiesParkinson's Disease (PD)+1 more
Danish Research Centre for Magnetic Resonance 100
Very early researchLooking for participantsNCT07640542
What this trial is testing

Test-retest Trial With [11C]MODAG-005 in PD or MSA and AMHC - Pilot Phase

Who this might be right for
Parkinson Disease (PD)MSA - Multiple System AtrophyHealthy Adult Participants
MODAG GmbH 9
Testing effectiveness (Phase 2)Ended earlyNCT02871427
What this trial is testing

Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder

Who this might be right for
Lewy Body DementiaDementia With Lewy BodiesParkinson's Disease Dementia+2 more
Axovant Sciences Ltd. 80
Not applicableStudy completedNCT03076671
What this trial is testing

More Than a Movement Disorder: Applying Palliative Care to Parkinson's Disease

Who this might be right for
Parkinson DiseaseParkinsonismLewy Body Disease+8 more
University of Colorado, Denver 783
Very early researchStudy completedNCT06445465
What this trial is testing

Study to Evaluate a Potential PET Radioligand for Imaging Alpha-synuclein Deposits in the Brain

Who this might be right for
Alpha-SynucleinopathyParkinson's DiseaseDementia With Lewy Bodies+1 more
Invicro 12
Not applicableStudy completedNCT01380899
What this trial is testing

Usefulness of α-synuclein as a Marker for Early Diagnosis of Parkinson's Disease in Skin Biopsy.

Who this might be right for
Parkinson DiseaseParkinsonian Disorders
Universidad Autonoma de San Luis Potosí 87
Next Page